Uttar Pradesh, India

Chndan Singh

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2006.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chndan Singh: Innovator in Antimalarial Research

Introduction

Chndan Singh is a notable inventor based in Uttar Pradesh, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antimalarial agents. His innovative work has led to the creation of a unique class of compounds that hold promise in combating malaria.

Latest Patents

Chndan Singh holds a patent for "Amino-functionalized 1,2,4-trioxanes useful as antimalarial agents and process for preparation thereof." This invention relates to a novel series of antimalarial amino functionalized 1,2,4-trioxane analogues, where Ar represents various aryl groups such as phenyl, 4-biphenyl, and 4-chlorophenyl. The compounds are designed to enhance the efficacy of antimalarial treatments.

Career Highlights

Chndan Singh is affiliated with the Council of Scientific and Industrial Research, where he conducts research and development in the field of pharmaceuticals. His work has been instrumental in advancing the understanding and treatment of malaria through innovative chemical solutions.

Collaborations

Chndan has collaborated with notable colleagues such as Sunil Kumar Puri and Heetika Malik. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in antimalarial drug development.

Conclusion

Chndan Singh's contributions to the field of antimalarial research exemplify the impact of innovative thinking in addressing global health challenges. His patent and ongoing research efforts continue to pave the way for new therapeutic options in the fight against malaria.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…